jolkinolide b has been researched along with Laryngeal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dong, L; Kang, S; Liu, D; Liu, F; Wang, J; Yang, X | 1 |
1 other study(ies) available for jolkinolide b and Laryngeal Neoplasms
Article | Year |
---|---|
Jolkinolide B attenuates laryngeal cancer cell growth and induces apoptosis via PTEN/PI3K/Akt signaling pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromones; Diterpenes; Flow Cytometry; Fluorescent Antibody Technique; Humans; Hylobatidae; Insulin-Like Growth Factor I; Laryngeal Neoplasms; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Real-Time Polymerase Chain Reaction; Signal Transduction | 2021 |